Nobukazu Fujimoto

ORCID

Publication Activity (10 Years)

Years Active: 2015-2024
Publications (10 Years): 19

Top Venues

PloS one

BMJ case reports

Therapeutic advances in medical oncology

BMC cancer

This page only lists publications with an associated author ORCID identifier.

Publications

Nobukazu Fujimoto, Ayumi Akamatsu, Chikara Honda, Miki Aoki, Yuichiro Ohe
Real-world safety of nivolumab in patients with malignant pleural mesothelioma in Japan: post-marketing surveillance study. Japanese journal of clinical oncology (2024)
Hiromasa Yamamoto, Junichi Soh, Norihito Okumura, Hiroyuki Suzuki, Masao Nakata, Toshiya Fujiwara, Kenichi Gemba, Isao Sano, Takuji Fujinaga, Masafumi Kataoka, Yasuhiro Terazaki, Nobukazu Fujimoto, Kazuhiko Kataoka, Shinji Kosaka, Motohiro Yamashita, Hidetoshi Inokawa, Masaaki Inoue, Hiroshige Nakamura, Yoshinori Yamashita, Katsuyuki Hotta, Hiroshige Yoshioka, Satoshi Morita, Keitaro Matsuo, Junichi Sakamoto, Hiroshi Date, Shinichi Toyooka
Randomized phase II study of daily versus alternate-day administrations of S-1 for the elderly patients with completely resected pathological stage IA (tumor diameter > 2 cm)-IIIA of non-small cell lung cancer: Setouchi Lung Cancer Group Study 1201. PloS one 18 (5) (2023)
Hiromasa Yamamoto, Junichi Soh, Norihito Okumura, Hiroyuki Suzuki, Masao Nakata, Toshiya Fujiwara, Kenichi Gemba, Isao Sano, Takuji Fujinaga, Masafumi Kataoka, Yasuhiro Terazaki, Nobukazu Fujimoto, Kazuhiko Kataoka, Shinji Kosaka, Motohiro Yamashita, Hidetoshi Inokawa, Masaaki Inoue, Hiroshige Nakamura, Yoshinori Yamashita, Katsuyuki Hotta, Hiroshige Yoshioka, Satoshi Morita, Keitaro Matsuo, Junichi Sakamoto, Hiroshi Date, Shinichi Toyooka
Randomized phase II study of daily versus alternate-day administrations of S-1 for the elderly patients with completely resected pathological stage IA (tumor diameter > 2 cm)-IIIA of non-small cell lung cancer: Setouchi Lung Cancer Group Study 1201. PloS one 18 (5) (2023)
Seiki Hasegawa, Yasushi Shintani, Teruhisa Takuwa, Keisuke Aoe, Katsuya Kato, Nobukazu Fujimoto, Yasuhiro Hida, Masahiro Morise, Yasumitsu Moriya, Takao Morohoshi, Hidemi Suzuki, Masayuki Chida, Shunsuke Endo, Mitsutaka Kadokura, Meinoshin Okumura, Satoshi Hattori, Hiroshi Date, Ichiro Yoshino
Nationwide prospective registry database of patients with newly diagnosed untreated pleural mesothelioma in Japan. Cancer science (2023)
Hiromasa Yamamoto, Junichi Soh, Norihito Okumura, Hiroyuki Suzuki, Masao Nakata, Toshiya Fujiwara, Kenichi Gemba, Isao Sano, Takuji Fujinaga, Masafumi Kataoka, Yasuhiro Terazaki, Nobukazu Fujimoto, Kazuhiko Kataoka, Shinji Kosaka, Motohiro Yamashita, Hidetoshi Inokawa, Masaaki Inoue, Hiroshige Nakamura, Yoshinori Yamashita, Katsuyuki Hotta, Hiroshige Yoshioka, Satoshi Morita, Keitaro Matsuo, Junichi Sakamoto, Hiroshi Date, Shinichi Toyooka
Randomized phase II study of daily versus alternate-day administrations of S-1 for the elderly patients with completely resected pathological stage IA (tumor diameter > 2 cm)-IIIA of non-small cell lung cancer: Setouchi Lung Cancer Group Study 1201. PloS one 18 (5) (2023)
Takaaki Tanaka, Soma Nii, Hidenaru Yamaoka, Nobukazu Fujimoto
Severe cardiotoxicity induced by osimertinib in a patient with EGFR-mutated adenocarcinoma of the lung. BMJ case reports 16 (7) (2023)
Hisashi Tanaka, Shigeru Tanzawa, Toshihiro Misumi, Tomonori Makiguchi, Megumi Inaba, Takeshi Honda, Junya Nakamura, Koji Inoue, Takayuki Kishikawa, Masanao Nakashima, Keiichi Fujiwara, Tadashi Kohyama, Hiroo Ishida, Shoichi Kuyama, Naoki Miyazawa, Tomomi Nakamura, Hiroshi Miyawaki, Naohiro Oda, Nobuhisa Ishikawa, Ryotaro Morinaga, Kei Kusaka, Nobukazu Fujimoto, Yasushi Fukuda, Masayuki Yasugi, Takeshi Tsuda, Sunao Ushijima, Kazuhiko Shibata, Takuo Shibayama, Akihiro Bessho, Kyoichi Kaira, Kenshiro Shiraishi, Noriyuki Matsutani, Nobuhiko Seki
A phase II study of S-1 and cisplatin with concurrent thoracic radiotherapy followed by durvalumab for unresectable, locally advanced non-small-cell lung cancer in Japan (SAMURAI study): primary analysis. Therapeutic advances in medical oncology 14 (2022)
Hisashi Tanaka, Shigeru Tanzawa, Toshihiro Misumi, Tomonori Makiguchi, Megumi Inaba, Takeshi Honda, Junya Nakamura, Koji Inoue, Takayuki Kishikawa, Masanao Nakashima, Keiichi Fujiwara, Tadashi Kohyama, Hiroo Ishida, Shoichi Kuyama, Naoki Miyazawa, Tomomi Nakamura, Hiroshi Miyawaki, Naohiro Oda, Nobuhisa Ishikawa, Ryotaro Morinaga, Kei Kusaka, Nobukazu Fujimoto, Yasushi Fukuda, Masayuki Yasugi, Takeshi Tsuda, Sunao Ushijima, Kazuhiko Shibata, Takuo Shibayama, Akihiro Bessho, Kyoichi Kaira, Kenshiro Shiraishi, Noriyuki Matsutani, Nobuhiko Seki
A phase II study of S-1 and cisplatin with concurrent thoracic radiotherapy followed by durvalumab for unresectable, locally advanced non-small-cell lung cancer in Japan (SAMURAI study): primary analysis. Therapeutic advances in medical oncology 14 (2022)
Yosuke Miyamoto, Toshiyuki Kozuki, Keisuke Aoe, Sae Wada, Daijiro Harada, Michihiro Yoshida, Jun Sakurai, Katsuyuki Hotta, Nobukazu Fujimoto
JME-001 phase II trial of first-line combination chemotherapy with cisplatin, pemetrexed, and nivolumab for unresectable malignant pleural mesothelioma. Journal for immunotherapy of cancer 9 (10) (2022)
Yuki Takigawa, Daisuke Mizuno, Norichika Iga, Nobukazu Fujimoto
Catamenial pneumothorax due to heterotopic endometriosis in the pericardium. BMJ case reports 14 (2) (2021)
Takumi Kishimoto, Nobukazu Fujimoto, Keiichi Mizuhashi, Satoko Kozawa, Motohiko Miura
Retrospective investigation on diagnostic process for benign asbestos pleural effusion (BAPE) using checklist. Journal of occupational health 62 (1) (2021)
Kazuya Nishii, Masaaki Inoue, Hideto Obata, Yutaka Ueda, Toshiyuki Kozuki, Masahiro Yamasaki, Tomonori Moritaka, Yoshikazu Awaya, Keisuke Sugimoto, Kenichi Gemba, Shoichi Kuyama, Hirohisa Ichikawa, Takuo Shibayama, Tetsuya Kubota, Masahiro Kodani, Daizo Kishino, Nobukazu Fujimoto, Nobuhisa Ishikawa, Yukari Tsubata, Tomoya Ishii, Kazunori Fujitaka, Katsuyuki Hotta, Katsuyuki Kiura
Novel prospective umbrella-type lung cancer registry study for clarifying clinical practice patterns: CS-Lung-003 study protocol. Thoracic cancer 12 (5) (2021)
Takaaki Tanaka, Yosuke Miyamoto, Atsue Sakai, Nobukazu Fujimoto
Nivolumab for malignant peritoneal mesothelioma. BMJ case reports 13 (11) (2020)
Morihito Okada, Takashi Kijima, Keisuke Aoe, Terufumi Kato, Nobukazu Fujimoto, Kazuhiko Nakagawa, Yuichiro Takeda, Toyoaki Hida, Kuninobu Kanai, Fumio Imamura, Satoshi Oizumi, Toshiaki Takahashi, Mitsuhiro Takenoyama, Hiroshi Tanaka, Jun Hirano, Yoshinobu Namba, Yuichiro Ohe
Clinical Efficacy and Safety of Nivolumab: Results of a Multicenter, Open-label, Single-arm, Japanese Phase II study in Malignant Pleural Mesothelioma (MERIT). Clinical cancer research : an official journal of the American Association for Cancer Research 25 (18) (2019)
Yasuko Nagamatsu, Isao Oze, Keisuke Aoe, Katsuyuki Hotta, Katsuya Kato, Junko Nakagawa, Keiko Hara, Takumi Kishimoto, Nobukazu Fujimoto
Physician requests by patients with malignant pleural mesothelioma in Japan. BMC cancer 19 (1) (2019)
Kenji Takada, Nobukazu Fujimoto, Taichi Ozeki, Jun Nishimura, Yosuke Miyamoto, Michiko Asano, Yasuko Fuchimoto, Sae Wada, Shinji Ozaki, Takuro Igawa, Hiroshi Sonobe, Takumi Kishimoto
Small intestinal intussusception in an adult. Journal of clinical pathology 72 (7) (2019)
Yasuko Nagamatsu, Isao Oze, Keisuke Aoe, Katsuyuki Hotta, Katsuya Kato, Junko Nakagawa, Keiko Hara, Takumi Kishimoto, Nobukazu Fujimoto
Quality of life of survivors of malignant pleural mesothelioma in Japan: a cross sectional study. BMC cancer 18 (1) (2018)
Tomoko Yamagishi, Nobukazu Fujimoto, Yosuke Miyamoto, Naofumi Hara, Michiko Asano, Yasuko Fuchimoto, Sae Wada, Kenichi Kitamura, Shinji Ozaki, Hideyuki Nishi, Takumi Kishimoto
The Rapid Appearance and Disappearance of Dendriform Pulmonary Ossification after Diffuse Alveolar Hemorrhage. American journal of respiratory and critical care medicine 193 (3) (2016)
Tomoko Yamagishi, Nobukazu Fujimoto, Yosuke Miyamoto, Michiko Asano, Yasuko Fuchimoto, Sae Wada, Kenichi Kitamura, Shinji Ozaki, Hideyuki Nishi, Takumi Kishimoto
Brain metastases in malignant pleural mesothelioma. Clinical & experimental metastasis 33 (3) (2015)

Nobukazu Fujimoto.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Nobukazu Fujimoto